By Bob Bondaryk, CEO – August 29, 2012
It’s been quite a busy year for KeraFAST, your trusted purveyor of rare and unique life science research products.
KeraFAST Moves to the Innovation District on the Boston Waterfront
(L-R: Kendalle Burlin O’Connell, director of Strategic Alliances/In-House Counsel for MassBio; Peter Meade, director of the Boston Redevelopment Authority; Robert Bondaryk, CEO of KeraFAST, Inc.; and Susan Windham-Bannister, president and CEO of the Massachusetts Life Sciences Center, celebrate the opening of KeraFAST’s new headquarters in Boston’s Innovation District.
Read more about our move: Ribbon Cutting Press Release [PDF].
33 Institutions Now Providing One-of-a-Kind-Materials in The Investigator’s Annexe™
One of our latest One-of-a-Kind-Materials
Anti-phospho ATR (T1989) monoclonal antibody, a highly specific probe for Thr 1989 phosphorylation of active Ataxia Telangiectasia-mutated and Rad3-Related (ATR) kinase from the laboratory of David Cortez, PhD, at Vanderbilt University Medical Center, is one of our newest and fastest-selling products, only available in The Investigator’s Annexe™.
Vanderbilt joins 33 Institutions now in The IA™ offering similar rare, unique and otherwise-difficult-to-access research materials to the global research community. View the full list of participating institutions »
Want to join or learn more about The IA™? Visit www.theInvestigatorsAnnexe.com/join.
KeraFAST Moving Forward in 2012…
- Hundreds of rare, unique and otherwise-difficult-to-access products now for sale. Need something you don’t see in our catalog? Tell us here.
- Brisk sales now to life scientists in research in academia and industry on 5 continents.
- Closed on venture capital round with FCA Venture Partners [PDF] in March to finance our growth.
- We opened a new Investigator’s Annexe website TheInvestigatorsAnnexe.com
- We’ve had six successive quarters of cutting royalty checks to The IA™ Member institutions. Learn more about receiving academic funding in The IA.
- Added permanent staff and interns from both the North Carolina Biotechnology Center and the Massachusetts Life Science Center.